--- title: 'Clinical Supply Planning Manager at Summit Therapeutics' canonical: 'https://feeny.ai/job/clinical-supply-planning-manager-summit-therapeutics-princeton-f0fgx028v3hb' type: 'job' last_seen: '2026-11-06' --- # Clinical Supply Planning Manager at Summit Therapeutics - **Company:** Summit Therapeutics - **Location:** Princeton, NJ - **Compensation:** $139k–$142k - **Posted:** 2026-10-16 - **Last confirmed live:** 2026-11-06 - **Apply:** https://job-boards.greenhouse.io/summittherapeutics/jobs/4456435009 ## Job description About Summit: Summit Therapeutics Inc. is a biopharmaceutical oncology company with a mission focused on improving quality of life, increasing potential duration of life, and resolving serious unmet medical needs. At Summit, we believe in building a team of world class professionals who are passionate about this mission, and it is our people who drive this mission to reality. Summit’s core values include integrity, passion for excellence, purposeful urgency, collaboration, and our commitment to people. Our employees are truly the heart and soul of our culture, and they are invaluable in shaping our journey toward excellence. Summit’s team is inspired to touch and help change lives through Summit’s clinical studies in the field of oncology. Summit has multiple global Phase 3 clinical studies, including: Non-small Cell Lung Cancer (NSCLC) - HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI. - HARMONi-3: Phase 3 clinical study which is intended to evaluate ivonescimab combined with chemotherapy compared to pembrolizumab combined with chemotherapy in patients with first-line metastatic NSCLC. - HARMONi-7: Phase 3 clinical study which is intended to evaluate ivonescimab monotherapy compared to pembrolizumab monotherapy in patients with first-line metastatic NSCLC. Colorectal Cancer (CRC) - HARMONi-GI3: Phase 3 clinical study intended to evaluate ivonescimab in combination with chemotherapy compared with bevacizumab plus chemotherapy. Ivonescimab is an investigational therapy not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA). Summit is headquartered in Miami, Florida, and has additional offices in California, New Jersey, the UK, and Ireland. Job Title: Clinical Supply Planning Manager Department: Supply Chain Location: Palo Alto, CA / Miami, FL / Princeton, NJ ## CLINICAL SUPPLY PLANNING MANAGER Overview of Role: The Clinical Supply Planning Manager provides planning, analytics, coordination, and operational support to the Associate Director, Clinical Supply and Clinical Supply Managers across Summit’s portfolio of internally and externally sponsored global clinical trials. The role consolidates demand, maintains inventory and supply visibility, prepares scenarios and performance insights, coordinates planning activities, and supports approved supply, allocation, release, and logistics plans. The position works cross-functionally with internal teams, depots, manufacturers, and other external partners to maintain accurate planning information, identify and escalate risks, and support timely execution. Clinical Supply Managers retain accountability for study-level strategy, decisions, and execution. Role and Responsibilities: - Consolidate study and portfolio demand forecasts to support Summit’s integrated clinical supply planning process. - Prepare planning inputs, dashboards, meeting materials, and decision-support analyses for the CMC/Supply Chain team. - Run and review vendor reports; maintain accurate depot-, product-, and batch-level inventory visibility across Summit’s global supply network. - Maintain approved demand forecasts, inventory plans, allocation assumptions, supply scenarios, and related planning data in designated systems and trackers as the single source of truth. - Develop demand, inventory, expiry, resupply, and allocation scenarios and provide recommendations - Support inventory allocation planning and execute approved allocation decisions across depots, considering study priorities, shipment timing, regulatory approvals, shelf life, and other identified constraints. - Coordinate and facilitate monthly clinical supply planning reviews, including data preparation, risk summaries, decisions, action tracking, and follow-up. - Produce and maintain KPIs, trend analyses, risk assessments, and recommendations to support management decisions and continuous improvement. - Identify, assess, document, and escalate inventory constraints, expiry risks, release delays, forecast changes, and potential supply interruptions; support mitigation planning with the responsible Clinical Supply Manager. - Coordinate monthly supply-plan updates with Clinical Supply Managers, depot teams, manufacturers, and other external partners, and implement updates resulting from approved decisions. - Coordinate cross-functionally to gather and track QA/QP release, GMP, shipment, importation, and other required documentation to support operational readiness. - Maintain action, decision, risk, assumption, and dependency logs and follow assigned items through closure. - Provide analysis and operational support for the development and implementation of approved clinical supply strategies, timelines, budgets, and process improvements. - Communicate effectively with internal and external stakeholders and promptly escalate issues requiring management attention or decisions. - Perform other duties as assigned. Experience, Education and Specialized Knowledge and Skills: - Bachelor’s degree in Life Sciences, Pharmacy, Supply Chain, Business, or a related field; equivalent relevant experience may be considered. - 5+ years of relevant experience in clinical supply planning, pharmaceutical or biotechnology supply chain, or a related operations environment preferred. - Working knowledge of clinical supply concepts, including demand forecasting, inventory management, allocation, shelf life, packaging and labeling, release readiness, distribution, and depot operations. - Experience supporting multiple studies or products in a global, cross-functional, and outsourced operating model preferred. - Strong analytical and problem-solving skills, with the ability to translate data into clear risks, scenarios, and recommendations. - Strong proficiency in Excel and experience with demand-planning, forecasting, inventory, or reporting tools strongly preferred. - Excellent written and verbal communication skills, with the ability to prepare concise analyses and coordinate effectively with internal teams and external partners. - Strong organization, attention to detail, time management, and follow-through across multiple priorities and deadlines. - Proactive and able to work independently within defined responsibilities, while escalating decisions, risks, and exceptions appropriately. - Ability to adapt to changing priorities and work cross-functionally across geographies and time zones in a fast-paced biotechnology environment. This is the pay for this position Pay Transparency $139,000—$142,000 USD Actual compensation packages are based on several factors that are unique to each candidate, including but not limited to skill set, depth of experience, certifications, and specific work location. This may be different in other locations due to differences in the cost of labor. The total compensation package for this position may also include bonus, stock, benefits and/or other applicable variable compensation. Summit does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact Summit’s Talent Acquisition team at recruiting@smmttx.com to obtain prior written authorization before referring any candidates to Summit. Summit Therapeutics Inc. is an Equal Opportunity Employer and takes pride in creating and maintaining diverse environment. We do not discriminate in recruitment, hiring, training or promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. ## About Summit Therapeutics ## Company Overview - **One-liner**: Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on discovering, developing, and commercializing novel bispecific antibody therapies, with its lead candidate ivonescimab targeting PD-1 and VEGF for multiple solid tumors. - **Entity Type**: Public (NASDAQ: SMMT) - **Headquarters**: Miami, Florida, USA (with additional offices in Palo Alto, CA; Princeton, NJ; Oxford, UK; and Dublin, Ireland) - **Founded**: 2003 - **Founders**: Not publicly disclosed on the company website; the company was founded in 2003. ## Core Business - **Primary industry**: Biopharmaceuticals / Oncology - **Target customers**: B2B (healthcare providers, patients, and caregivers) with a focus on resolving serious unmet medical needs in oncology - **Mission statement**: "To resolve serious, unmet medical needs for the betterment of overall human health." [smmttx.com](https://smmttx.com/company/about-us/default.aspx) ## Products & Services - **Ivonescimab (SMT112)**: A novel, potential first-in-class investigational bispecific antibody targeting both PD-1 and VEGF. It is designed to combine immunotherapy (PD-1 blockade) with anti-angiogenesis (VEGF blockade) into a single molecule. Currently being studied in several global Phase 3 clinical trials for non-small cell lung cancer (NSCLC), colorectal cancer (CRC), and head and neck squamous cell carcinoma (HNSCC). Licensed from Akeso, Inc. (HKEX: 9926.HK) for territories including the U.S., Canada, Europe, Japan, Latin America, the Middle East, and Africa. [smmttx.com](https://smmttx.com/pipeline/default.aspx) ## Market Standing - **Valuation/Market Cap**: Approximately $2.7 billion (as of recent data) [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - **Key Metric**: Annual revenue of approximately $705,000 (reported). The company is pre-commercialization and heavily investing in R&D. Total funding raised since IPO (2015) is not disclosed, but the company has a strong cash position from equity offerings. - **Notable Investors/Partners**: Akeso, Inc. (key licensing partner for ivonescimab). The company is publicly traded with institutional and retail investors. - **Growth Signals**: - Headcount grew 72.5% year-over-year to 244 employees. [linkedin.com](https://www.linkedin.com/company/summit-therapeutics) - Multiple global Phase 3 trials actively recruiting (HARMONi, HARMONi-3, HARMONi-7, HARMONi-GI3, ILLUMINE). - Over 4,000 patients have been treated with ivonescimab across all clinical trials globally. [smmttx.com](https://smmttx.com/pipeline/default.aspx) - Achieved Great Place to Work® Certification. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) ## Competitive Advantages - **Novel Mechanism**: Ivonescimab is a first-in-class bispecific antibody targeting both PD-1 and VEGF simultaneously, potentially offering superior efficacy and fewer side effects compared to combination therapies. - **Speed and Execution**: The company emphasizes "high-speed execution in commercialization" and has rapidly initiated multiple Phase 3 trials. - **Global Reach**: Licensed territories cover major markets (U.S., Canada, Europe, Japan, Latin America, Middle East, Africa) with a strong partner (Akeso) in the rest of the world. - **Strong Balance Sheet**: With a $2.7B market cap and public listing, the company has access to capital markets to fund its pipeline. ## Strategic Focus - **Current priorities**: Advancing ivonescimab through Phase 3 clinical trials across multiple solid tumor indications (NSCLC, CRC, HNSCC), with the goal of regulatory approval and commercialization. - **Future direction**: Expanding the pipeline into additional solid tumors and leveraging the bispecific platform for future therapies. The company is focused on becoming a leading oncology player. - **Near-term milestones**: Data readouts from ongoing Phase 3 trials, potential regulatory submissions, and building commercial infrastructure. ## Why Work Here - **Culture**: The company has achieved Great Place to Work® Certification, indicating a positive, supportive, and fulfilling work environment. Core values include Commitment to People, Integrity, Passion for Excellence, Purposeful Urgency, Accountability, and Collaboration. [smmttx.com](https://smmttx.com/careers/careers-overview/default.aspx) - **Work Environment**: Fast-paced, high-energy atmosphere focused on innovation and collaboration. The company emphasizes "making a significant difference in patients’ lives." - **Benefits (U.S.)**: - 401(k) with 6% employer match - Employee Stock Purchase Plan (ESPP) with 15% discount up to the annual federal limit - Flexible Spending Account - Commuter Benefit - Onsite lunch provided - **Benefits (U.K.)**: - Private Medical Insurance - Employee Assistance Program - Life Assurance Policy - Company Pension Contributions - ESPP - **Remote/Hybrid Policy**: Not explicitly stated, but multiple office locations suggest a hybrid or on-site presence is expected for many roles. - **Open Roles**: 25 active job postings (as of recent data) including Senior Director of Sales Operations, Clinical Scientists, Medical Science Liaisons, and Drug Product MSAT roles. [greenhouse.io](https://job-boards.greenhouse.io/summitherrapeutics) - **Headcount Growth**: 72.5% year-over-year growth signals a scaling organization with opportunities for career advancement. ## Sources 1. [smmttx.com - About Us](https://smmttx.com/company/about-us/default.aspx) 2. [smmttx.com - Investor Relations Overview](https://www.smmttx.com/overview/default.aspx) 3. [smmttx.com - Pipeline](https://smmttx.com/pipeline/default.aspx) 4. [smmttx.com - Careers Overview](https://smmttx.com/careers/careers-overview/default.aspx) 5. [linkedin.com - Summit Therapeutics Company Page](https://www.linkedin.com/company/summit-therapeutics) 6. [greenhouse.io - Summit Therapeutics Careers](https://job-boards.greenhouse.io/summitherrapeutics) ## Other roles at Summit Therapeutics - [Executive Oncology Account Manager (Asheville)](https://feeny.ai/job/executive-oncology-account-manager-asheville-summit-therapeutics-asheville-xea3xrskjcqw) — Asheville, NC - [Executive Oncology Account Manager (Portland)](https://feeny.ai/job/executive-oncology-account-manager-portland-summit-therapeutics-portland-0cjhm9gw84jh) — Portland, OR - [Executive Oncology Account Manager (Memphis)](https://feeny.ai/job/executive-oncology-account-manager-memphis-summit-therapeutics-memphis-n4vbnmrsdwqb) — Memphis, TN - [Executive Oncology Account Manager (Des Moines)](https://feeny.ai/job/executive-oncology-account-manager-des-moines-summit-therapeutics-des-moines-a8wf1x3paf3y) — Des Moines, IA - [Executive Oncology Account Manager (Knoxville)](https://feeny.ai/job/executive-oncology-account-manager-knoxville-summit-therapeutics-knoxville-g3gr9z1f730s) — Knoxville, TN - [Associate Director, CMC / Quality Project Management](https://feeny.ai/job/associate-director-cmc-quality-project-management-summit-therapeutics-princeton-0bc35yd129z5) — Princeton, NJ - [Senior Clinical Trial Manager](https://feeny.ai/job/senior-clinical-trial-manager-summit-therapeutics-remote-6zvca64c4wcr) - [Executive Oncology Account Manager (Fort Worth)](https://feeny.ai/job/executive-oncology-account-manager-fort-worth-summit-therapeutics-fort-worth-q76xdp78qxqz) — Fort Worth, TX - [Executive Oncology Account Manager (Cincinnati)](https://feeny.ai/job/executive-oncology-account-manager-cincinnati-summit-therapeutics-cincinnati-yr41k1s11h9s) — Cincinnati, OH - [Executive Oncology Account Manager (Worcester)](https://feeny.ai/job/executive-oncology-account-manager-worcester-summit-therapeutics-worcester-ggnt93btghw6) — Worcester, MA